InsidersTradesSigma
Total declarations
Companies
▲ Purchases (4 ops.)
▼ Sales (7 ops.)
Insider track record
Board DirectorDisclosed buys
4
Disclosed sells
7
T+90 hit rate
0%
T+90 mean return
-25.3%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Valantine Hannah, Director. Officer active across 3 companies, notably CareDx, Inc.. Aggregated, 37 disclosures have been recorded. Split: 4 buys · 7 sells. Total volume traded: €1.2m. History available since 1 July 2021. The latest transaction was disclosed on 16 July 2026 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Valantine Hannah
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations37 total
5,125 shares@ US$7.960.0026% mcap2.4% of flowCommon StockSEC:0001855608-26-000004:2
28,679 shares@ US$36.14450.067% mcap62.2% of flowCommon StockSEC:0001855608-26-000004:3
100 shares@ US$36.550.0002% mcap0.2% of flowCommon StockSEC:0001855608-26-000004:4
7,606 shares@ US$20.560.010% mcap9.4% of flowCommon StockSEC:0001855608-26-000004:0
16,048 shares@ US$14.190.015% mcap13.7% of flowCommon StockSEC:0001855608-26-000004:1
3,990 sharesCommon StockSEC:0001470831-26-000635:0
2,808 sharesCommon StockSEC:0001470831-26-000635:1
2,808 sharesCommon StockSEC:0001470831-26-000635:2
2,196 sharesCommon StockSEC:0001470831-26-000635:3
9,795 sharesCommon StockSEC:0001855608-26-000003:0
12,103 sharesCommon StockSEC:0001855608-26-000003:1
8,671 shares@ US$27.367.3% of flowCommon StockSEC:0001470831-26-000260:0
25,484 shares@ US$48.4537.6% of flowCommon StockSEC:0001470831-26-000236:0
25,484 shares@ US$48.4569.4% of flowCommon StockSEC:0001470831-25-000317:0
1,752 shares@ US$14.244.7% of flowCommon StockSEC:0000950170-25-091759:0
Canonical exit: 29 Mar 2022 (T+90)
1,542 shares@ US$12.683.7% of flowCommon StockSEC:0000950170-25-091756:0
Canonical exit: 28 Mar 2022 (T+90)
876 shares@ US$44.10997.0% of flowCommon StockSEC:0000950170-25-091762:0
6,589 shares0Common StockSEC:0000950170-25-089643:0
10,570 shares@ US$19.1642100.0% of flowCommon StockSEC:0000950170-25-089022:0
12,103 shares0Common StockSEC:0000950170-25-087412:0
4,292 shares@ US$16.7515.8% of flowCommon StockSEC:0000950170-25-084914:0
12,875 shares@ US$16.7556.0% of flowCommon StockSEC:0000950170-25-036420:0
22,821 shares0Common StockSEC:0001299130-24-000156:0
10,570 shares0Common StockSEC:0000950170-24-074950:0
2,915 shares@ US$8.456.4% of flowCommon StockSEC:0000950170-24-017081:0
25 of 37 declarations
About Valantine Hannah
Valantine Hannah is Administrateur and appears in 32 filings in total. Across the 32 sampled filings, the reported buy volume is EUR 83489 and the reported sell volume is EUR 209537, with filings ranging from 2021-07-02 to 2026-06-24. The recent filings concern BridgeBio Pharma, Inc., CareDx, Inc. and Pacific Biosciences of California, INC., and the modal transaction nature is Attribution.
